This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, Yale University. Active years: 2022-2026.
Company Filing History:
2 out of 5,633 
2 out of 1,365 
Years Active: 2022-2026
Title: The Innovations of Chunxiao Fu
Introduction
Chunxiao Fu is an accomplished inventor based in Pearland, TX (US). He has made significant contributions to the field of hormonal therapy, particularly in relation to breast cancer treatment. With a total of 2 patents, his work has the potential to impact the lives of many patients.
Latest Patents
Chunxiao Fu's latest patents focus on methods for determining tumoral sensitivity to hormonal therapy. The first patent introduces the sensitivity to endocrine therapy index (SETindex), which assesses estrogen receptor (ER) and progesterone receptor (PR)-related genes. This method may also consider the proportion of ER gene (ESR1) RNA transcripts containing mutations. The second patent presents a similar approach, referred to as the sensitivity to endocrine therapy index (SETER/PR index), which also evaluates the same parameters for effective treatment of breast cancer patients.
Career Highlights
Chunxiao Fu has worked at prestigious institutions such as Yale University and The University of Texas System. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Chunxiao Fu has collaborated with notable colleagues, including Rosanna Lau and Bruno Sinn. Their combined expertise has further advanced the research and development of innovative therapies.
Conclusion
Chunxiao Fu's work exemplifies the importance of innovation in medical research, particularly in the treatment of breast cancer. His patents and collaborations highlight his commitment to improving patient outcomes through targeted hormonal therapies.